drugset / Trial / NCT01835470

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

NCT01835470

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of Abatacept after intravenous administration in Japanese children and adolescents with active juvenile idiopathic arthritis who have a history of an inadequate response or intolerance to Methotrexate or biologics

Timeline

Start
2013-08-09
Primary completion
2015-11-24
Completion
2018-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Abatacept Other / unclassified 10 mg/kg Intravenous
Subject Abatacept Other / unclassified 750 mg Intravenous
Subject Abatacept Other / unclassified 1 g Intravenous